Susquehanna International Group, LLP Organon & Co. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$18.65 - $23.03 $412,164 - $508,963	-22,100 Reduced 6.56%	315,000 $6.03 Million
Q2 2024 Aug 15, 2024	SELL	$17.45 - $21.96 $6.74 Million - $8.49 Million	-386,500 Reduced 53.41%	337,100 $6.98 Million
Q1 2024 May 07, 2024	SELL	$13.78 - $18.8 $1.57 Million - $2.14 Million	-113,800 Reduced 13.59%	723,600 $13.6 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $7.24 Million - $11.4 Million	660,900 Added 374.45%	837,400 $12.1 Million
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $509,313 - $729,739	30,700 Added 21.06%	176,500 $3.06 Million
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $3.26 Million - $4.17 Million	-169,300 Reduced 53.73%	145,800 $3.03 Million
Q1 2023 May 16, 2023	BUY	$21.42 - $32.08 $4 Million - $5.99 Million	186,800 Added 145.6%	315,100 $7.41 Million
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $2.18 Million - $2.68 Million	-93,500 Reduced 42.16%	128,300 $3.58 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $1.26 Million - $1.84 Million	53,800 Added 32.02%	221,800 $5.19 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.